ARCHIVES OF RHEUMATOLOGY, vol.32, no.2, pp.91-95, 2017 (Peer-Reviewed Journal)
Objectives: This study aims to assess the level of pentraxin-3 (PTX-3) as an inflammatory marker and compare it with C-reactive protein (CRP) levels in patients with Behcet's disease (BD).